Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2016 1
2017 1
2018 3
2019 8
2020 12
2021 8
2022 9
2023 3
2024 4
2025 5
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Methods and operational framework of GALFLU: Individually randomized pragmatic controlled trial of high- versus standard-dose influenza vaccination in older adults.
Mallah N, Pardo-Seco J, Rodriguez-Tenreiro-Sánchez C, Giné-Vázquez I, Mirás-Carballal S, Piñeiro-Sotelo M, Cribeiro-González M, Conde-Pájaro M, González-Pérez JM, Razzini JL, Rivero-Calle I, Dacosta-Urbieta AI, Harris RC, Loiacono MM, van Aalst R, Farre JM, Dufournet M, Johansen ND, Modin D, Biering-Sørensen T, Duran-Parrondo C, Martinón-Torres F; GALFLU trial team. Mallah N, et al. Among authors: van aalst r. Vaccine. 2026 Apr 19;79:128435. doi: 10.1016/j.vaccine.2026.128435. Epub 2026 Mar 9. Vaccine. 2026. PMID: 41806760 Free article.
High-Dose Influenza Vaccination in Atherosclerotic Cardiovascular Disease: A Multinational Pooled Analysis of DANFLU-2 and GALFLU (FLUNITY-HD).
Pareek M, Johansen ND, Modin D, Pardo-Seco J, Rodriguez-Tenreiro-Sánchez C, Loiacono MM, Harris RC, Dufournet M, van Aalst R, Chit A, Larsen CS, Larsen L, Wiese L, Dalager-Pedersen M, Claggett BL, Janstrup KH, Duran-Parrondo C, Piñeiro-Sotelo M, Cribeiro-González M, Conde-Pájaro M, Mirás-Carballal S, González-Pérez JM, Solomon SD, Sivapalan P, Martel CJ, Jensen JUS, Martinón-Torres F, Biering-Sørensen T; DANFLU-2 Study Group and GALFLU Trial Team. Pareek M, et al. Among authors: van aalst r. J Am Coll Cardiol. 2026 Feb 9:S0735-1097(25)10661-X. doi: 10.1016/j.jacc.2025.12.080. Online ahead of print. J Am Coll Cardiol. 2026. PMID: 41706066 Free article. No abstract available.
High-Dose Versus Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older Adults: The FLUNITY-HD Prespecified Pooled Analysis.
Johansen ND, Modin D, Pardo-Seco J, Rodriguez-Tenreiro-Sánchez C, Loiacono MM, Harris RC, Dufournet M, van Aalst R, Chit A, Larsen CS, Larsen L, Wiese L, Dalager-Pedersen M, Claggett BL, Janstrup KH, Duran-Parrondo C, Piñeiro-Sotelo M, Cribeiro-González M, Conde-Pájaro M, Mirás-Carballal S, González-Pérez JM, Solomon SD, Sivapalan P, Martel CJ, Jensen JUS, Martinón-Torres F, Biering-Sørensen T; DANFLU-2 Study Group and the GALFLU Trial Team. Johansen ND, et al. Among authors: van aalst r. Circulation. 2026 Mar 17;153(11):798-806. doi: 10.1161/CIRCULATIONAHA.125.077801. Epub 2025 Nov 10. Circulation. 2026. PMID: 41212981 Free PMC article.
Effectiveness of high-dose influenza vaccine against hospitalisations in older adults (FLUNITY-HD): an individual-level pooled analysis.
Johansen ND, Modin D, Pardo-Seco J, Rodriguez-Tenreiro-Sánchez C, Loiacono MM, Harris RC, Dufournet M, van Aalst R, Chit A, Larsen CS, Larsen L, Wiese L, Dalager-Pedersen M, Claggett BL, Janstrup KH, Duran-Parrondo C, Piñeiro-Sotelo M, Cribeiro-González M, Conde-Pájaro M, Mirás-Carballal S, González-Pérez JM, Solomon SD, Sivapalan P, Martel CJ, Jensen JUS, Martinón-Torres F, Biering-Sørensen T; DANFLU-2 Study Group; GALFLU Trial Team. Johansen ND, et al. Among authors: van aalst r. Lancet. 2025 Nov 22;406(10518):2425-2434. doi: 10.1016/S0140-6736(25)01742-8. Epub 2025 Oct 17. Lancet. 2025. PMID: 41115437 Clinical Trial.
High-Dose Influenza Vaccine to Reduce Hospitalizations.
Pardo-Seco J, Rodríguez-Tenreiro-Sánchez C, Giné-Vázquez I, Mallah N, Mirás-Carballal S, Piñeiro-Sotelo M, Cribeiro-González M, Conde-Pájaro M, González-Pérez JM, Rivero-Calle I, Bello X, Razzini JL, Dacosta-Urbieta A, Salas A, Harris RC, Loiacono MM, van Aalst R, Farré JM, Dufournet M, Johansen ND, Modin D, Biering-Sørensen T, Durán-Parrondo C, Martinón-Torres F; GALFLU Trial Team. Pardo-Seco J, et al. Among authors: van aalst r. N Engl J Med. 2025 Dec 11;393(23):2303-2312. doi: 10.1056/NEJMoa2509834. Epub 2025 Aug 30. N Engl J Med. 2025. PMID: 40888694 Clinical Trial.
52 results